Primary LAMP-2 deficiency causes X-linked vacoular cardiomyopathy and myopathy (Danon disease)

被引:627
|
作者
Nishino I. [1 ,3 ]
Fu J. [2 ]
Tanji K. [1 ]
Yamada T. [4 ]
Shimojo S. [5 ]
Koori T. [6 ]
Mora M. [7 ]
Riggs J.E. [8 ]
Oh S.J. [9 ]
Koga Y. [10 ]
Sue C.M. [1 ]
Yamamoto A. [3 ]
Murakami N. [3 ]
Shanske S. [1 ]
Byrne E. [11 ]
Bonilla E. [1 ]
Honaka I. [3 ]
DiMauro S. [1 ]
Hirano M. [1 ]
机构
[1] Department of Neurology, Columbia University, New York, NY 10032, 630 West 168th Street
[2] Dept. of Genetics and Development, Columbia University, New York, NY 10032, 630 West 168th Street
[3] Dept. of Ultrastructural Research, National Institute of Neuroscience, Natl. Ctr. of Neurol. and Psychiatry, Kodaira, Tokyo 187-8502
[4] Department of Neurology, Kyushu University, Fukuoka 812-8582, 3-1-1 Maidashi, Higashi-ku
[5] Department of Internal Medicine, S. Marianna Univ. School of Medicine, Kawasaki, Kanagawa 216-8512, 2-16-1 Sugao, Miyamae-ku
[6] Department of Pediatrics, Yokohama Rosai Hospital, Yokohama Kanagawa 222-0036, 321 Kozukue-cho, Kouhoku-ku
[7] Department of Neuromuscular Diseases, Natl. Neurol. Institute C. Besta, Milan 20133
[8] Department of Neurology, West Virginia University, Morgantown, WV 26506
[9] Department of Neurology, University of Alabama at Birmingham, UAB Station, Birmingham
[10] Dept. of Pediatrics and Child Health, Kurume University, Kurume, Fukuoka 830-0011
[11] Department of Clinical Neuroscience, St. Vincents Hospital, Fitzroy
关键词
D O I
10.1038/35022604
中图分类号
学科分类号
摘要
'Lysosomal glycogen storage disease with normal acid maltase', which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intra-cytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease4. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
引用
收藏
页码:906 / 910
页数:4
相关论文
共 50 条
  • [31] A 5′ dystrophin duplication mutation causes membrane deficiency of α-dystroglycan in a family with X-linked cardiomyopathy
    Bies, RD
    Maeda, M
    Roberds, SL
    Holder, E
    Bohlmeyer, T
    Young, JB
    Campbell, KP
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (12) : 3175 - 3188
  • [32] X-linked myotubular myopathy: an untreated treatable disease
    Martin, Cristina
    Servais, Laurent
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, : 379 - 394
  • [33] A phenocopy of sarcomeric hypertrophic cardiomyopathy: LAMP2 cardiomyopathy (Danon disease) from China
    Maron, Barry J.
    EUROPEAN HEART JOURNAL, 2012, 33 (05) : 570 - 572
  • [34] LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease
    Michelle Rothaug
    Stijn Stroobants
    Michaela Schweizer
    Judith Peters
    Friederike Zunke
    Mirka Allerding
    Rudi D’Hooge
    Paul Saftig
    Judith Blanz
    Acta Neuropathologica Communications, 3
  • [35] Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease
    Echaniz-Laguna, A
    Mohr, M
    Epailly, E
    Nishino, I
    Charron, P
    Richard, P
    Guiraud-Chaumeil, C
    Tranchant, C
    MUSCLE & NERVE, 2006, 33 (03) : 393 - 397
  • [36] Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)
    Samad, Fatima
    Jain, Renuka
    Jan, M. Fuad
    Sulemanjee, Nasir Z.
    Menaria, Puneet
    Kalvin, Lindsey
    Bush, Michelle
    Jahangir, Arshad
    Khandheria, Bijoy K.
    Tajik, A. Jamil
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 245 : 201 - 206
  • [37] LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease
    Rothaug, Michelle
    Stroobants, Stijn
    Schweizer, Michaela
    Peters, Judith
    Zunke, Friederike
    Allerding, Mirka
    D'Hooge, Rudi
    Saftig, Paul
    Blanz, Judith
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 6
  • [38] XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
    Stéphanie Rigaud
    Marie-Claude Fondanèche
    Nathalie Lambert
    Benoit Pasquier
    Véronique Mateo
    Pauline Soulas
    Lionel Galicier
    Françoise Le Deist
    Frédéric Rieux-Laucat
    Patrick Revy
    Alain Fischer
    Geneviève de Saint Basile
    Sylvain Latour
    Nature, 2006, 444 : 110 - 114
  • [39] XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
    Marsh, Rebecca A.
    Madden, Lisa
    Kitchen, Brenda J.
    Mody, Rajen
    McClimon, Brad
    Jordan, Michael B.
    Bleesing, Jack J.
    Zhang, Kejian
    Filipovich, Alexandra H.
    BLOOD, 2010, 116 (07) : 1079 - 1082
  • [40] XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
    Rigaud, Stephaine
    Fondaneche, Marie-Claude
    Lambert, Nathalie
    Pasquier, Benoit
    Mateo, Veronique
    Soulas, Pauline
    Galicier, Lionel
    Le Deist, Francoise
    Rieux-Laucat, Frederic
    Revy, Patrick
    Fischer, Alain
    de Saint Basile, Genevieve
    Latour, Sylvain
    NATURE, 2006, 444 (7115) : 110 - 114